New Insights on Psoriatic Arthritis from ACR 2024

A New ACR
Apremilast Benefits and Risks in PsA
Best Things I Saw Today in PsA
Bimekizumab in PsA Showed Sustained Reductions in Disease Impact
Biologic Monotherapy vs Combination with cDMARDs in PsA
Do TNFis and JAKis Prevent Cancer!?
Improvements in Pain and Fatigue in Bimekizumab
Long-term Safety Profile of Bimekizumab in axSpA and PsA
Potential Impact of Weight Loss Drugs in Rheumatic Diseases
Proposed ACR Guidance for Use of MSUS in Psoriatic Arthritis
PsA Potpourri
PsA Ultrasound Updates
PsA: Impact of Sex
Sex Differences in Psoriatic Arthritis
The Psoriatic March: PsA before PsO
Apremilast in PsA: Results from Mosaic Trial
Anti IL-17 on Entheseal Biopsy in PsA